相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
常温,避光
- 克隆性:
单克隆
- 抗体名:
CD74 / DHLAG / p33 抗体
抗体类型: Rabbit Polyclonal Antibody ( Antibody Purification Platform )
抗体宿主 : Rabbit IgG
缓冲液 : 0.2 μm filtered solution in PBS, 5% trehalose may be added in some batches. Please read the hardcopy of COA or contact our customer service to confirm the formulation.
制备方法 : Produced in rabbits immunized with purified, human cell-derived, recombinant human CD74 extracellular domain ( rh CD74; Catalog#11091-H07H; NP_004346.1; Gln 73 - Met 232 ). Total IgG was purified by Protein A affinity chromatography
CD74 / DHLAG / p33抗体背景综述
Human CD74, also known as HLA-DR antigens-associated invariant chain or Ii, is a non-polymorphic glycoprotein, which is expressed on antigen-presenting cells (APC), and carcinomas of renal, lung, gastric, thymic origin and by certain sarcomas. It is post-translationally glycosylated and exists in different isoforms. The most common isoform is 33 kDa (p33), but p35, p41 and p43 isoforms also exist. The most well-known function of CD74 is regulating the trafficking of class Ⅱ major histocompatibility complex (MHC) proteins in APC. It also acts as a surface membrane receptor for macrophage migration inhibitory factor (MIF), alone or together with CD44. But multiple studies have revealed that cell surface expression of CD74 is not always dependent on class Ⅱ MHC. The role of CD74 in signal transduction was initially hypothesized when it was found to be phosphorylated and associated with proteins that coordinate various signal transduction pathways. CD74 was recently found to be increased in microglia in Alzheimer disease (AD) cases compared to age-matched controls. Additionally, it may be useful targets to reduce neutrophilic lung inflammation, and acute lung injury. Various studies have indicated that CD74 is highly expressed in inflammatory disorders and cancers. Thus, the restricted expression of CD74 by normal tissues and its very rapid internalization make CD74 an attractive therapeutic target for both cancer and immunologic diseases.
CD74 / DHLAG / p33 抗体相关产品如下:xy-4848R phospho-RUNX3(Ser338)磷酸化Runx3抗体
xy-2933R RAB-14RAS相关蛋白癌基因Rab14抗体
xy-5696R phospho-p107(Ser975)磷酸化视网膜母细胞瘤样蛋白p107抗体
xy-5697R phospho-RelB(Ser551)磷酸化转录因子RelB蛋白抗体
xy-2163R RNF148环指蛋白148抗体
xy-2794R RGS5G蛋白信号转导调节因子5抗体
xy-2777R Rb成视网膜细胞瘤基因抗体
xy-2149R SPRN新朊蛋白抗体
xy-4188R SGPL1磷酸鞘氨醇裂解酶1抗体
xy-7358R se-selectin可溶性E选择素
xy-8620R sp-selectin可溶性P选择素抗体
xy-1888R SCG3分泌粒蛋白3抗体
xy-1034R SP-B肺表面活性蛋白B抗体
xy-1135R SRCsrc原癌基因抗体
xy-1220R SPAG4L生精细胞凋亡相关基因4抗体
xy-3600R Syntrophin Alpha1神经肌肉接头蛋白SNTA1抗体
xy-1331R sFRP-4子宫内膜抗体
xy-7934R SHOC2富含亮氨酸重复蛋白SHOC2抗体
xy-7772R SEPT14细胞分化蛋白SEPT14抗体
xy-11952R SLC12A6钾氯离子转运蛋白3抗体
xy-11953R SLC25A12钙结合线粒体载体蛋白抗体
xy-11954R SLC5A3钠离子肌醇转运蛋白抗体
xy-11693R Senataxin肌萎缩侧索硬化症相关蛋白4抗体
xy-11702R SH3GL3胞浆蛋白SH3GL3抗体
xy-10149R ABCG8三磷酸腺苷结合转运蛋白G超家族成员8抗体
xy-11955R SLITRK2神经突触相关蛋白SLITRK2抗体
xy-11956R SLITRK3神经突触相关蛋白SLITRK3抗体
xy-11957R SLITRK4神经突触相关蛋白SLITRK4抗体
xy-11959R SLITRK5神经突触相关蛋白SLITRK5抗体
xy-11960R SLITRK6神经突触相关蛋白SLITRK6抗体
xy-11961R SNAIL + SLUG锌指转录因子Slug+SNAIL抗体
xy-11962R phospho-SNAIL + SLUG (Ser246)磷酸化锌指转录因子Slug+SNAIL抗体
xy-11963R SORCS2液泡蛋白分选受体SORCS2抗体
xy-11964R SOX21转录因子21抗体
xy-11965R SPOCK1睾丸蛋白聚糖1抗体
xy-11966R SPOCK2睾丸蛋白聚糖2抗体
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验人转录因子E2F1 ( E2F1 )ELISA 试剂盒 原理 本实验采用双抗体夹心 ABC-ELISA 法。用抗人 E2F1 单抗包被于酶标板上,标准品和样品中的 E2F1与单抗结合,加入生物素化的抗人 E2F1 ,形成免疫复合物连接在板上,辣根过氧化物酶标记的 Streptavidin 与生物素结合,加入底物工作液显蓝色,最后加终止液硫酸,在 450nm 处测 OD 值,E2F1 浓度与 OD 值成正比
X性联无丙种球蛋白血症(X-linked agammagl,bulinemia,XLA)是临床上首次确定的体液免疫缺陷病,由Brutor于1952年报道,故又称Bruton病。XLA作为常见的原发性免疫缺陷病之一,特点为血清中各类免疫球蛋白缺乏,或只能测得微量的抗体。外周血和淋巴组织中B细胞减少或完全缺乏,淋巴结中无生发中心和浆细胞。本病起病早,在出生数月后当患儿体内的母源性抗体水平下降时开始发病。临床表现为反复化脓性感染,患者细胞免疫功能不受影响(部分患者有T细胞数量减少),主要缺陷
ChIP是一种强大的确定蛋白或者组蛋白修饰在基因组上定位的实验方法。染色质被分离出来后采用抗体与抗原的结合来判定目的蛋白是否结合在特定的DNA序列上或者判定目的蛋白结合位点在全基因组范围的分布(微阵列或DNA序列)。这种方法具有空间性与时效性。该实验设计为如何在细胞中进行ChIP实验提供了详细的步骤。1. 交联和细胞收获甲醛可以将蛋白质交联到DNA上。交联结果的好坏决定于交联时间的把握。我们建议样品交联的时间一般为2-30分钟。过度的交联会减少抗原的结合性和超声断裂的效率。抗原决定簇也会被掩盖
技术资料暂无技术资料 索取技术资料




